• CVS Health, Salesforce Enlarging Their Roles In Clinical Research

    Mar 19, 2021, 01:00 by User Not Found
    Clinical Research News | Hyper-local engagement and hyper-customized communications are both are necessary as the industry continues its shift toward decentralized clinical trial strategies, and the needs have prompted the entry of non-pharma companies into the clinical research space, including CVS Health and Salesforce, according to a keynote presentation at the recent Summit for Clinical Ops Executives (SCOPE).
    Full story
  • Reengineering Trials Is An Organizational Imperative

    Mar 18, 2021, 01:00 by User Not Found
    Clinical Research News | In the space of a year, the clinical trials enterprise has made “a decade of progress” in the way it conducts studies, according to Harlan Krumholz, cofounder of Hugo Health, who spoke about participant-partnered research at the recent Summit for Clinical Ops Executives (SCOPE).
    Full story
  • How Active Safety Analytics Can Help Pharma Companies Increase Public Confidence in COVID-19 Vaccines

    Mar 17, 2021, 01:00 by User Not Found
    Clinical Research News | The biggest US vaccine initiative is currently underway, with 32.3 million people having received at least one dose of either Pfizer-BioNTech or Moderna’s COVID-19 vaccine—including 37 million who have been fully vaccinated—as of the second week of March.
    Full story
  • Award-Winning Participant Engagement Strategies

    Mar 16, 2021, 01:00 by User Not Found
    Clinical Research News | A lot of technology companies talk about the importance of patient input on the products they build, but Medidata is the first to hire patient advocates to provide feedback throughout the development life cycle—specifically, the patient cloud products it deploys in clinical trials, says Alicia Staley, senior director of patient engagement. “We’ve put a process in place to hold our own feet to the fire,” she says. “If our patient advocates haven’t looked at something rolling out the door, an explanation is expected as to why not.”
    Full story
  • How To Integrate The Patient Voice Into Trial Design

    Mar 15, 2021, 14:13 by User Not Found
    Clinical Research News | The need to listen to the voice of patients at the right time, in the right context, and in their own language was a dominant theme of a live panel session at the recent Summit for Clinical Ops Executives (SCOPE) where views were shared on integrating patient insights into clinical trial design.
    Full story
  • Clinical Control Tower Providing Near-Real-Time View Of GSK Trials

    Mar 12, 2021, 13:00 by User Not Found
    Clinical Research News | Thanks to COVID-19, asset leads at GlaxoSmithKline (GSK) can now tap a Clinical Control Tower for answers to five critical questions about how studies are progressing and if they are veering off course. The platform was developed last year to enable trial leaders to maintain business continuity during the pandemic.
    Full story
  • Antibodies Plus Vaccines, RWD on Post-Shot Reactions: COVID-19 Updates

    Mar 12, 2021, 11:20 by User Not Found
    Clinical Research News | Top COVID-19 news and research stories of the week: real-world data from Mass General Brigham staff after vaccination, antibodies and the jab, and springtime impacts on infection rates.
    Full story
  • SCOPE 2021 Highlights New Value Props From Vendors

    Mar 11, 2021, 01:00 by User Not Found
    Clinical Research News | New products, acquisitions, and a Cannes Film Festival award—some of the noteworthy announcements heard on the virtual exhibit hall floor during SCOPE 2021.
    Full story
  • Alfa Chemistry Released Ion Sensor Materials for Analytical and Chromatography Applications

    Mar 10, 2021, 10:08 by
    Full story
  • AARDEX and Schreiner MediPharm reinforce their collaboration to Enhance Medication Adherence Management

    Mar 10, 2021, 10:08 by
    AARDEX Group, the world leader in medication adherence solutions, continues to build up its ecosystem and to bridge GMP to GCP world in Clinical Trials by reinforcing their strategic partnership with Schreiner MediPharm, a global specialist in innovative functional labels and smart packaging solutions for the pharmaceutical industry.
    Full story
  • Vanessa Research Proudly Supported Rare Disease Day

    Mar 10, 2021, 10:03 by
    Rare Disease Day is observed internationally on the last day of February to raise awareness regarding the 300 million people worldwide who are battling rare diseases. Vanessa Research proudly supported Rare Disease Day for the fourth consecutive year. Unlike years past, in 2021 events were virtual because of the ongoing global COVID-19 pandemic.
    Full story
  • Shimmer Launches Pulse+ the First Line Extension for its Verisense® Wearable Sensing Platform for Clinical Trials

    Mar 10, 2021, 10:03 by
    Shimmer’s Verisense platform can now measure clinical trial participants’ heart rate, oxygen saturation and emotional responses in addition to their activity and sleep levels.
    Full story
  • New personalised therapeutics partner joins Repositive Cancer Model network

    Mar 10, 2021, 10:03 by
    Repositive has today announced that Vivan Therapeutics, an innovative personalised therapeutics company, will be the next company to join its global network of cancer model partners. Vivan Therapeutics has unique experience in engineering drosophila ‘avatar’ models for cancer research and development unique experience in engineering drosophila ‘avatar’ models for cancer research and development.
    Full story
  • CD Bioparticles Releases Chitosans for Research Use

    Mar 10, 2021, 10:03 by
    CD Bioparticles launches a series of chitosans for global research communities to support drug delivery studies.
    Full story
  • BOC Sciences Upgrades Organelle Fluorescent Probe Product List

    Mar 10, 2021, 10:03 by
    Full story
  • 108Labs Launches Colostrupedics™ Whole-Human Infant Formula with Secretory Antibodies

    Mar 10, 2021, 10:03 by
    108Labs announces Colostrupedics™ whole-human infant formula, made possible with the discovery of novel secretory antibody biosynthesis. This is the first animal-free infant formula that exclusively comprises cell-cultured human milk molecules derived from human mammary cell agriculture and formulated with broadly-neutralizing human secretory antibodies.
    Full story
  • Cytel’s East Bayes® Broadens & Simplifies Access to Complex Bayesian Clinical Trial Designs

    Mar 10, 2021, 10:03 by
    Cytel has launched East Bayes®, an enhanced web-based extension of the East® platform that enables adoption of the most computationally intensive Bayesian clinical trial designs – without the need for powerful on-site computers.
    Full story
  • Leinco Technologies, Inc. and La Jolla Institute for Immunology announce license agreement to develop novel COVID-19 diagnostic tools

    Mar 10, 2021, 10:03 by
    Leinco Technologies, Inc., a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, and conjugates, has signed a licensing agreement with La Jolla Institute for Immunology (LJI), one of the leading research organizations dedicated to studying the immune system, to develop novel COVID-19 diagnostics tools.
    Full story
  • PCR Biosystems launches advanced Bst Polymerase reagents for accelerated DNA and RNA amplification

    Mar 10, 2021, 10:03 by
    PCR Biosystems have launched a range of IsoFast™ Bst Polymerase reagents for rapid, robust and sensitive DNA and RNA amplification. Without the need for high temperature denaturation or specialised thermocycling equipment, IsoFast™ Bst Polymerase enables faster results and can be used in the field. This makes it ideal for a range of applications including environmental and food pathogen testing and clinical diagnostics – including for qualitative detection of the SARS-CoV-2 nucleic acid.
    Full story
  • SB3000 ApS has been awarded a grant from the Danish Innovation Fund, to further refine its continuous manufacturing enabling technology μLOT® which will revolutionise the production of medicines

    Mar 10, 2021, 10:03 by
    SB3000 received grant funding from Danish Innovation Fund for its continuous manufacturing enabling technology for medicine production.
    Full story
  • «
  • 151
  • 152
  • 153
  • 154 (current)
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • »